Laurion Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Laurion Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-10,092	Closed	-$975K	–	1263
2020 Q2	$975K	Buy	+10,092	New	+$842K	0.01%	468
2020 Q1	–	Sell	-12,700	Closed	-$926K	–	1214
2019 Q4	$926K	Buy	+12,700	New	+$770K	0.01%	584
2019 Q2	–	Sell	-40,768	Closed	-$2.12M	–	1285
2019 Q1	$2.12M	Buy	+40,768	New	+$1.88M	0.03%	305
2016 Q4	–	Sell	-29,347	Closed	-$480K	–	1353
2016 Q3	$480K	Buy	+29,347	New	+$530K	﹤0.01%	658

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Laurion Capital Management's MYOK Position: Q3 2020 in Review

Laurion Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 10,092 shares — an estimated $975K sold.

Laurion Capital Management first reported a position in MYOK in Q3 2016 and held it in 4 quarters. The position peaked at $2.12M in Q1 2019. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

Laurion Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Laurion Capital Management sold 10,092 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $975K.
Laurion Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q3 2016 and held it in 4 quarters.
Laurion Capital Management's MyoKardia, Inc. Common Stock position peaked at $2.12M in Q1 2019.
237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Laurion Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.